Newsletter | August 20, 2026

08.20.26 -- Set Quality Expectations Before Your CDMO Starts

SPONSOR

Cell Bank Manufacturing

Your master cell bank (MCB) is critical to therapeutic product development, in addition to supporting clinical development, manufacturing, and commercial supply of biologics. Put your bank in the hands of the experts and get it right the first time.

FOCUS ON OUTSOURCING

Defining Quality In A Sponsor-Owned QTPP Before The CDMO Even Starts

Version-controlled quality target product profiles, authored by the drug sponsor, close any gaps between the CDMO's and sponsor's definitions of quality.

De-Risking A Novel Valve Component For Use With Standard Syringe Systems

A novel valve provides dual‑chamber functionality within standard syringes, keeping two liquid drugs separated until injection while reducing development risk through advanced modeling.

Precision Control In Animal‑Free Raw Materials

Animal‑free raw materials offer adjustable attributes, controlled manufacturing, and consistent nutrient profiles, ensuring reliable performance and customizable solutions across multiple production processes.

Trends Shaping The Future Of Cell And Gene Therapy Manufacturing

Discover how automation and digitalization are transforming cell and gene therapy with scalable, decentralized manufacturing and smarter market navigation.

Developing Scalable, Global Solutions For Cell & Gene Manufacturing

Cell and gene therapies offer transformative potential for treating complex diseases, but their manufacturing and global delivery face significant challenges.

The Right Partnerships Are Key To Streamlined Drug Development

Explore how to select the right CDMO partner for your pharmaceutical project to navigate the evolving drug development landscape and ensure successful outcomes.

Development, Manufacture Of Biopharmaceuticals In Microbial Systems

We discuss the trends in new molecular formats, which is one of the current drivers of renewed interest in fermentation technologies, along with some of their challenges. 

Single-Use In Sterile Manufacturing: Where It Adds Flexibility

Single-use systems improve sterile manufacturing by boosting flexibility, reducing changeovers, and lowering contamination risk—while supporting traditional systems based on scale and process needs.

A Platform For Advanced AAV Analytics

Advanced AAV analytics use high‑resolution multiplex platforms to assess genome integrity and capsid traits, improving accuracy, speeding development, and supporting regulatory quality control.

OUTSOURCING SOLUTIONS

Inside Simtra’s Expanding ADC Development Capabilities - Simtra BioPharma Solutions

Scalable Solutions For High Potent OSD Manufacturing - Recipharm

How Boehringer Is Scaling Large Molecule Manufacturing - Boehringer Ingelheim Biopharmaceuticals GmbH

Integrated ADC Offering: From Concept To Commercialization - Lonza

Avid Bioservices Capabilities Update June 2026: Cell Line Development - Avid Bioservices

AgentSCREEN™ GMP Adventitious Virus Detection By NGS - Minaris

Our Spokane Foreign Trade Zone (FTZ) - Jubilant HollisterStier

Pionyr: Selecting A CDMO To Scale-Up Manufacturing - Lonza

Connect With Bioprocess Online: